Lombard Odier Asset Management (Usa) Corp Takeda Pharmaceutical CO LTD Transaction History

Lombard Odier Asset Management (Usa) Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $807,499 - $899,499	-50,000 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$16.7 - $21.52 $417,500 - $538,000	25,000 Added 100.0%	50,000 $1.02 Million
Q1 2019 May 15, 2019	SELL	$16.7 - $21.52 $417,500 - $538,000	-25,000 Reduced 50.0%	25,000 $1.02 Million
Q4 2018 Feb 14, 2019	BUY	$15.64 - $21.1 $782,000 - $1.06 Million	50,000 New	50,000 $841,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.